Outsourcing in Clinical Trials Southern California 2021

The 2021 program boasts two full streams: Clinical Operations & Outsourcing, and Clinical Trial Technology & Innovation.

Attendees will hear from AbbVie, Pfizer, Arena Pharmaceuticals, Bristol Myers Squibb, ClearFlow, Daré Bioscience and many more. Mary Syto, Director of Early Clinical Development at Bristol Myers Squibb, will be leading the Clinical Operations stream on Day 1, whilst James Wabby, Executive Director of Regulatory Affairs & Combination Products/Device at AbbVie, will be heading up the Innovation stream. 

With a more interactive and hands on agenda including debates, workshops, roundtables, fireside chats and more, this event will create an environment where clinical trial teams from across all sizes of sponsor and vendor can work together to manage demands while ensuring patients are safeguarded at all stages.

Parexel is proud to be a Featured Sponsor of OCT SoCal

Join Parexel at this session:

December 7, 2021 - 10:00 am Plenary session: Significantly increase Asset value and global reach by including Asians in your early clinical development Stanford Jhee, Corporate Vice President Scientific Affairs - Parexel